G8867 – Pneumococcal vaccine not administered or previously received, reason not given
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG8867
- Long description
- Pneumococcal vaccine not administered or previously received, reason not given
- Short description
- No pneumococcal admin
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
M5BSpecialist - psychiatry- Added
- January 1, 2012
- Last change
- January 1, 2013 – No change
Frequently asked questions
What is HCPCS code G8867?
G8867 is a HCPCS Level II code for pneumococcal vaccine not administered or previously received, reason not given.
Does Medicare cover G8867?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G8859 – Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
- G8860 – Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
- G8861 – Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed
- G8862 – Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
- G8863 – Patients not assessed for risk of bone loss, reason not given
- G8864 – Pneumococcal vaccine administered or previously received
- G8865 – Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
- G8866 – Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
- G8868 – Patients receiving a first course of anti-tnf therapy
- G8869 – Patient has documented immunity to hepatitis b and initiating anti-tnf therapy
- G8870 – Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy
- G8871 – Patient not receiving a first course of anti-tnf therapy
- G8872 – Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
- G8873 – Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)
- G8874 – Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
- G8875 – Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.